Company Announcements

Directorate Change

Source: RNS
RNS Number : 4222Q
EMIS Group PLC
26 February 2021
 

26 February 2021

 

 

EMIS Group plc

("EMIS Group" or the "Company")

 

Directorate change

 

EMIS Group, the UK leader in connected healthcare software and systems, today announces the appointment of Jayaprakasa (JP) Rangaswami to the Board as an Independent Non-Executive Director.

 

JP Rangaswami will formally join the Board on 1 March 2021 and will be a member of the audit, remuneration and nomination committees.

 

JP's executive and non-executive experience has encompassed a range of sectors, with particular expertise in the data analytics sector in operational and strategic data-focussed and technology roles. His last executive role was as chief data officer and group head of innovation at Deutsche Bank. He also brings a strong understanding of working in a regulated environment having spent more than a decade in the financial services sector.

 

JP is currently a Non-Executive Director of Allfunds Bank SAU, Daily Mail and General Trust plc, Admiral Group plc and the National Bank of Greece.

 

Commenting on the appointment, Patrick De Smedt, Chairman of EMIS Group, said:

 

"It gives me great pleasure to welcome JP Rangaswami to the Board. He brings a wide range of data and technology skills and experience which complement and enhance the significant expertise we already have on the Board. We are looking forward to working with him."

 

The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

Full name: Jayaprakasa  Rangaswami

 

Age: 63

 

Current Directorships:

National Bank of Greece

Admiral Group plc

Cumberland Lodge

Hammersmith Academy Trust

Clive Street Limited

Allfunds Bank SAU

Daily Mail and General Trust plc

Web Science Trust appointed

 

Directorships held in the past five years:

None

 

There are no further disclosures to be made in connection with Schedule Two of paragraph (g) of the AIM rules for companies in connection with this appointment.

 

- ENDS -

 

For further information, contact:

 

EMIS Group plc                                                                               Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

 

Numis Securities Limited (Nominated Adviser & Broker)   Tel: 020 7260 1000

Oliver Hardy/Simon Willis/James Black

 

MHP Communications                                                                  Tel: 020 3128 8168

Reg Hoare/Giles Robinson/Florence Mayo/Pandora Yadgaroff         emis@mhpc.com        

 

Information for investors, including analyst consensus forecasts, can be found on the Group's website at www.emisgroupplc.com/investors.

 

 

Notes to Editors

 

EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

 

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

 

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

 

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses and patient-facing services.

 

 

 

LEI: 213800K474ZZK76NX913

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKPBPOBKDQBB